| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 164.600 +0.12% on 10/15/21 | | 170.400 -3.29% on 09/30/21 | unch (unch) since 09/17/21 |
| 3-Month | 107.400 +53.45% on 08/09/21 | | 176.000 -6.36% on 08/10/21 | +10.400 (+6.74%) since 07/16/21 |
| 52-Week | 100.000 +64.80% on 10/30/20 | | 176.000 -6.36% on 08/10/21 | +61.000 (+58.77%) since 10/16/20 |
PMI Global Services Inc. (PMI) (NYSE: PM) today announced that its offer for Vectura Group plc (Vectura) (LSE: VEC) has become unconditional, having received valid acceptances for or acquired 74.77 % of...
Novaremed AG, a privately held clinical-stage biopharmaceutical company, announces the acquisition of Metys Pharmaceuticals AG (Metys), including all of its development programs, in an all-share transaction....
Philip Morris International Inc. (PMI) (NYSE: PM) today announced it has published an offer document with U.K.-based Vectura Group plc (Vectura) (LSE: VEC) in connection with the recommended cash offer...
Regulatory News:
Philip Morris International Inc. (PMI) (NYSE: PM) announced today it has agreed with the board of Vectura Group plc (Vectura) (LSE: VEC) on the terms of an all-cash, recommended offer to acquire Vectura...
HANGZHOU, China, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology company focusing on discovering, developing and commercializing transformative...
Kinaset Therapeutics, Inc. (“Kinaset” or the “Company”), a newly-founded biopharmaceutical company, today announced a $40 million Series A financing with a blue-chip investor syndicate of 5AM...
DURHAM, N.C., June 08, 2020 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc. (“Aerami” or the “Company”) a clinical stage biopharmaceutical company developing inhaled therapies to treat severe respiratory...
| 3rd Resistance Point | 165.357 |
| 2nd Resistance Point | 165.179 |
| 1st Resistance Point | 164.989 |
| Last Price | 164.800 |
| 1st Support Level | 164.621 |
| 2nd Support Level | 164.443 |
| 3rd Support Level | 164.253 |
| 52-Week High | 176.000 |
| Last Price | 164.800 |
| Fibonacci 61.8% | 146.968 |
| Fibonacci 50% | 138.000 |
| Fibonacci 38.2% | 129.032 |
| 52-Week Low | 100.000 |